Korsana Biosciences, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| KRSA | PRTA | B9A.F | ACIU | DNLI | ALEC | |
|---|---|---|---|---|---|---|
| Market cap | 1.39B | 430.72M | 2.45B | 227.69M | 3.36B | 254.58M |
| P/E (TTM) | — | — | 250.7 | — | — | — |
| Forward P/E | -8.6 | -6.4 | — | 3.8 | -8.9 | -3.1 |
| Price/book | -3.9 | 1.5 | 1.2 | 4.3 | 3.6 | -25.6 |
| Dividend yield | — | — | 0.68% | — | — | — |
| 1-year change | +158.33% | −16.77% | +13.08% | −33.62% | +45.45% | +75.38% |
| Today | −4.38% | +2.19% | −0.29% | +9.57% | +7.76% | +11.22% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All KRSA news ›Korsana Biosciences to present at multiple investor conferences in November 2026
Korsana Biosciences announced its participation in several upcoming investor conferences in November 2026, including events hosted by Guggenheim, Stifel, UBS, and Jefferies. These presentations will feature discussions about the company's…
Maris Tech stake report lists 20.64% and 1.66%
Evaxion announces 89% vaccine target precision and sustained T-cell and clinical responses at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01 Phase III Trial Shows Veracyte’s Decipher Prostate Test Can Predict…
Korsana Biosciences: J. Wood reports 0.1% stake
A 25,974-share stake in Korsana Biosciences (KRSA) is held by J. Wood Capital Advisors. Stock Titan - [SCHEDULE 13G/A] Korsana Biosciences, Inc. Amended Passive Investment Disclosure Korsana Biosciences: J. Wood reports 0.1% stake Korsana…
Korsana Biosciences sets Nov. 13 Cayman move vote
Separate two-thirds voting tests govern the proposed change, and uncast shares count against the domestication proposal. If both proposals pass and required filings are made, Korsana anticipates effectiveness as soon as practicable after…
Net current asset value per share of Korsana Biosciences, Inc. – NASDAQ:KRSA
TradingView Net current asset value per share of Korsana Biosciences, Inc.
Equity in earnings of Korsana Biosciences, Inc. – NASDAQ:KRSA
TradingView Equity in earnings of Korsana Biosciences, Inc.
Enterprise value to EBIT forward of Korsana Biosciences, Inc. – NASDAQ:KRSA
TradingView Enterprise value to EBIT forward of Korsana Biosciences, Inc.
Operating income of Korsana Biosciences, Inc. – NASDAQ:KRSA
TradingView Operating income of Korsana Biosciences, Inc.
Korsana Biosciences proposes Cayman Islands domicile move
ZIM Raises Full-Year 2026 Guidance At the August 26, 2026 meeting, 61.8% of votes cast supported the proposal, representing 44.8% of eligible shares. Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net4
- tradingview.com4
- pluang.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 9 articles, not a forecast.